Published in PLoS One on June 03, 2009
Neuronal autoantigens--pathogenesis, associated disorders and antibody testing. Nat Rev Neurol (2012) 3.20
Immunologic privilege in the central nervous system and the blood-brain barrier. J Cereb Blood Flow Metab (2012) 1.30
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer (2011) 1.10
Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies: A beneficial antitumor immune response going awry. Oncoimmunology (2013) 0.99
T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation. Eur J Immunol (2014) 0.79
CD8(+) T Cell-Mediated Neuronal Dysfunction and Degeneration in Limbic Encephalitis. Front Neurol (2015) 0.78
Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodies. Neuro Oncol (2012) 0.78
Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. Physiol Rev (2017) 0.78
Cell-mediated immune responses in paraneoplastic neurological syndromes. Clin Dev Immunol (2013) 0.76
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med (1992) 22.13
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (1998) 9.77
Paraneoplastic syndromes involving the nervous system. N Engl J Med (2003) 5.46
Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol (2003) 4.76
Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med (2005) 4.06
Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat Immunol (2006) 3.85
Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) (1992) 3.21
CNS immune privilege: hiding in plain sight. Immunol Rev (2006) 3.13
What is immune privilege (not)? Trends Immunol (2006) 3.02
A hierarchy of Hu RNA binding proteins in developing and adult neurons. J Neurosci (1997) 2.76
Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis. Ann Neurol (1990) 2.58
Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol (1948) 2.53
Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc Natl Acad Sci U S A (1996) 2.52
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol (1997) 2.19
Basic principles of immunological surveillance of the normal central nervous system. Glia (2001) 2.13
Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med (1998) 2.11
Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies. Ann Neurol (1999) 1.91
An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J Exp Med (2007) 1.84
Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med (1998) 1.83
The RNA-binding protein HuD regulates neuronal cell identity and maturation. Proc Natl Acad Sci U S A (2005) 1.66
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J Immunol (2002) 1.54
Initiation of immune responses in brain is promoted by local dendritic cells. J Immunol (2004) 1.48
Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann Neurol (1995) 1.37
Immunobiology and privilege of neuronal retina and pigment epithelium transplants. Vision Res (2002) 1.25
Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors. Cancer Res (2000) 1.11
T cell response to Hu-D peptides in patients with anti-Hu syndrome. J Neurooncol (2005) 1.09
Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells. J Clin Invest (2009) 1.08
Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation. J Neuroimmunol (1999) 1.00
Peptides derived from the onconeural HuD protein can elicit cytotoxic responses in HHD mouse and human. J Neuroimmunol (2003) 0.97
A T-cell receptor associated with naturally occurring human tumor immunity. Proc Natl Acad Sci U S A (2007) 0.96
Cytotoxic T cell activity against peptides of Hu protein in anti-Hu syndrome. J Neurol Sci (2002) 0.94
Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis. Neurology (1994) 0.92
T cell receptor (TCR) recognition of MHC class I variants: intermolecular second-site reversion provides evidence for peptide/MHC conformational variation. J Exp Med (1996) 0.88
No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies. Cancer Immunol Immunother (2007) 0.84
A role for microglia in the maintenance of photoreceptors in retinal transplants lacking pigment epithelium. J Neurocytol (1992) 0.81
Myelin basic protein infused into cerebrospinal fluid suppresses experimental autoimmune encephalomyelitis. J Neuroimmunol (1991) 0.80
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature (2008) 14.17
Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature (2009) 14.07
De novo gene disruptions in children on the autistic spectrum. Neuron (2012) 9.69
CLIP identifies Nova-regulated RNA networks in the brain. Science (2003) 8.88
FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell (2011) 8.46
An RNA map predicting Nova-dependent splicing regulation. Nature (2006) 7.63
Nova regulates brain-specific splicing to shape the synapse. Nat Genet (2005) 6.58
CLIP: a method for identifying protein-RNA interaction sites in living cells. Methods (2005) 6.26
RNA processing and its regulation: global insights into biological networks. Nat Rev Genet (2010) 5.34
Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data. Nat Biotechnol (2011) 3.18
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. J Clin Oncol (2009) 2.89
An alternative mode of microRNA target recognition. Nat Struct Mol Biol (2012) 2.77
Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls. Science (2010) 2.69
Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol Cell (2012) 2.54
Splicing regulation in neurologic disease. Neuron (2006) 2.46
Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev (2005) 2.38
Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J Neurosci (2004) 2.20
Nova2 regulates neuronal migration through an RNA switch in disabled-1 signaling. Neuron (2010) 2.08
RNA binding proteins and the regulation of neuronal synaptic plasticity. Curr Opin Neurobiol (2006) 2.08
Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer. Mol Cell Biol (2003) 2.00
Nova autoregulation reveals dual functions in neuronal splicing. EMBO J (2005) 1.97
EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J (2012) 1.91
CLIP: crosslinking and immunoprecipitation of in vivo RNA targets of RNA-binding proteins. Methods Mol Biol (2008) 1.79
Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron (2012) 1.78
Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain. Genes Dev (2012) 1.70
Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer (2004) 1.55
Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs. Hum Mol Genet (2009) 1.53
Structure-function studies of FMRP RGG peptide recognition of an RNA duplex-quadruplex junction. Nat Struct Mol Biol (2011) 1.38
The TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development. EMBO J (2002) 1.38
Common molecular pathways mediate long-term potentiation of synaptic excitation and slow synaptic inhibition. Cell (2005) 1.36
A mouse model of the human Fragile X syndrome I304N mutation. PLoS Genet (2009) 1.36
Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol (2005) 1.35
Neuronal Elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Neuron (2012) 1.27
Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing. Proc Natl Acad Sci U S A (2009) 1.27
Evolution of Nova-dependent splicing regulation in the brain. PLoS Genet (2007) 1.23
Alternative splicing microarrays reveal functional expression of neuron-specific regulators in Hodgkin lymphoma cells. J Biol Chem (2004) 1.22
The fragile X mental retardation protein, FMRP, recognizes G-quartets. Ment Retard Dev Disabil Res Rev (2004) 1.14
IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation. J Immunol (2006) 1.13
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation. Blood (2006) 1.13
Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol (2004) 1.08
Patients with lung cancer and paraneoplastic Hu syndrome harbor HuD-specific type 2 CD8+ T cells. J Clin Invest (2009) 1.08
Prediction of clustered RNA-binding protein motif sites in the mammalian genome. Nucleic Acids Res (2013) 1.05
The Neuronal Splicing Factor Nova Co-Localizes with Target RNAs in the Dendrite. Front Neural Circuits (2010) 1.05
NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. Elife (2013) 1.03
Protein-RNA and protein-protein recognition by dual KH1/2 domains of the neuronal splicing factor Nova-1. Structure (2011) 1.01
A T-cell receptor associated with naturally occurring human tumor immunity. Proc Natl Acad Sci U S A (2007) 0.96
Cellular immune suppression in paraneoplastic neurologic syndromes targeting intracellular antigens. Arch Neurol (2012) 0.95
The onconeural antigen cdr2 is a novel APC/C target that acts in mitosis to regulate c-myc target genes in mammalian tumor cells. PLoS One (2010) 0.94
Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice. Hum Mol Genet (2013) 0.92
Functional and mechanistic insights from genome-wide studies of splicing regulation in the brain. Adv Exp Med Biol (2007) 0.91
Determination and augmentation of RNA sequence specificity of the Nova K-homology domains. Nucleic Acids Res (2004) 0.90
Observing the invisible: successful tumor immunity in humans. Nat Immunol (2003) 0.90
Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer. PLoS One (2010) 0.88
Sox21 is a repressor of neuronal differentiation and is antagonized by YB-1. Neurosci Lett (2004) 0.86
Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo. Elife (2013) 0.85
The neuronal splicing factor Nova controls alternative splicing in N-type and P-type CaV2 calcium channels. Channels (Austin) (2010) 0.82
T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation. Eur J Immunol (2014) 0.79
Ri/Nova gene-associated paraneoplastic subacute motor neuronopathy. Muscle Nerve (2013) 0.77
NMDA receptor as a target in paraneoplastic encephalitis. Ann Neurol (2007) 0.76
Turkey must end violent response to protests. Science (2013) 0.75
Erratum: Mapping Argonaute and conventional RNA-binding protein interactions with RNA at single-nucleotide resolution using HITS-CLIP and CIMS analysis. Nat Protoc (2016) 0.75
Autoimmune encephalopathy: the spectrum widens. Ann Neurol (2009) 0.75